Articles tagged with Cancer Cells
A recent in vitro study published in Journal of Dietary Supplements found that ergothioneine helped preserve telomere length and reduce oxidative stress. The study suggests that ergothioneine as part of a healthy diet could potentially mitigate the negative effects of oxidative stress and support healthy aging by preserving telomeres.
Scientists studying DNA damage repair process aim to identify a protein that can help healthy cells avoid dying or becoming cancerous. ATF3, a sensor of cell stress, has been shown to be essential to efficient DNA repair and may be the key to developing new cancer therapies.
Researchers found that women with low levels of senescence-associated secreted phenotypes (SASPs) had higher survival rates than those with high levels. Brachytherapy greatly improved survival in patients with high SASP levels, but had little impact on those with low levels.
A machine learning model developed in Finland can identify best cancer drug combinations to selectively kill specific cancer cells with unique genetic or functional profiles. The AI model accurately predicts how different drug combinations inhibit particular cancer cells, paving the way for more effective cancer treatments.
Scientists have developed a procedure, SCENITH, that identifies the energy status of immune and cancer cells within tumors to personalize treatment. This method uses protein synthesis as an indicator of cell activity, enabling clinicians to predict patient response and improve therapy efficacy.
A new imaging technology allows researchers to see multiple intracellular signals simultaneously, revealing their relationships and interactions. This breakthrough could illuminate complex processes like learning and memory, as well as diseases such as Alzheimer's and cancer.
A novel targeted therapy, POMHEX, has been developed to block metabolic pathways in brain cancer cells with specific genetic defects. The study found that the small-molecule enolase inhibitor effectively killed brain cancer cells missing ENO1, and showed promise in animal models of this type of cancer.
Researchers studied fruit fly ovaries to understand cellular motion, discovering that tissue geometry creates a path of least resistance. The team found that cells choose central paths despite multiple side paths available, and this choice is influenced by the physical space, not just chemical signals.
Researchers at Tel Aviv University developed a CRISPR-Cas9 system that specifically targets cancer cells, destroying them by genetic manipulation. The system improved the average life expectancy of mice with glioblastoma tumors by 30% and increased overall survival rate in metastatic ovarian cancer mice model by 80%.
Scientists at St. Jude Children's Research Hospital have identified how metabolic signaling pathways influence key immune cells, including eTreg cells. Understanding this regulation may aid in developing more specific drugs to target these pathways and treat diseases such as lupus, rheumatoid arthritis, and cancer.
A team of scientists at Tokyo University of Science has developed a novel synthesis method to create phenazinones, which show high cytotoxicity towards cancer cells. This breakthrough could lead to the creation of new anticancer drugs with minimal side effects.
Researchers at CeMM have developed a scalable method to study hundreds of proteins in parallel, enabling the observation of changes in protein levels and localization in real-time. This approach has potential applications in discovering new drug treatments and understanding proteome dynamics.
Researchers found a ubiquitin ligase complex that degrades miR-7 and other miRNAs in cells. This discovery sheds light on how cells dispose of genetic molecules regulating protein production.
Researchers at WPI will develop computational models to understand cellular forces and geometry during cell division. The study aims to identify factors that lead to defective spindle structure in cells, which can be targeted to promote cancer cell death.
A team of researchers has discovered how an enzyme called UCH37 helps cells get rid of damaged proteins. By removing branchpoints from ubiquitin chains, UCH37 allows proteins to be degraded more efficiently, which could lead to new cancer treatments.
Purdue University engineers have developed a microfluidic device that allows scientists to test drugs on multiple tumor cell subtypes, revealing new insights into drug resistance. The technology mimics the behavior of pancreatic cancer cells within a tumor, enabling researchers to identify effective treatment strategies.
Scientists have discovered a new role for the cancer-fighting gene p53 in preventing retrotransposons from hopping around the human genome, potentially leading to new ways of detecting or treating cancers. The study found that cells without functional p53 had higher rates of retrotransposon movement and multiplication.
Researchers from the University of Copenhagen have discovered how MCM proteins regulate DNA replication pace and preserve essential skill for life continuation in cells. Their findings suggest a potential way to exploit cancer weaknesses by manipulating molecular roadblocks that slow down DNA replication.
A new study by Brown University scientists has identified vimentin as a potential target for treating aggressive cancer cells known as polyploidal giant cancer cells (PGCCs). PGCCs have been found to rely on vimentin to migrate and invade surrounding tissues.
Researchers have developed a new cancer-specific anticancer drug that can prevent drug resistance and reduce side effects. The drug is designed to release an anticancer agent along with a drug-resistance inhibitor in cancer cells, effectively treating cancers without recurrence or treatment failure.
Researchers have identified silent ancient DNA elements in our genome that, when reactivated, stimulate the immune system to fight cancer. The discovery of ADAR1, an enzyme used by cancer cells to evade detection, opens up a new field of cancer therapies.
Researchers have discovered a novel mechanism by which cells detect and respond to mechanical stress, triggered by the deformation of their nuclei. This 'fight or flight' reflex allows cells to rapidly flee crowded environments, a process that is conserved across species and in adulthood.
A five-year, $10 million research effort will focus on understanding the three-dimensional structure of cell nuclei and its effects on cellular functions. Researchers aim to develop fundamental knowledge to provide insights into developmental disorders, aging, and other cell processes.
The study reveals that efavirenz alters the gene expression of important factors essential for genomic stability, particularly down-regulating S-phase and DNA replication genes. This suggests that efavirenz may be used in synergy with chemo/radiotherapy to treat lung cancer.
Scientists have identified the crucial role of RAD51 protein in recruiting TERRA molecules to telomeres, which helps prevent accidental loss or shortening of DNA. This mechanism is essential for maintaining healthy telomeres and preventing premature aging and age-related diseases.
The study finds that high miR-708 expression is associated with survival rates in lung squamous cell carcinoma patients. Additionally, miR-708 decreases proliferation, survival, and migration of lung cancer cells by inhibiting PGE2 signaling.
Researchers found that compressing cells can trigger cell growth and division, increasing stem-cell state. Squeezing intestinal cells activates specific proteins, leading to larger organoids with more stem cells on their surface.
Scientists created a 3D structural model of the BAF complex, which modifies DNA architecture and is frequently mutated in cancer. The new model provides critical insights into how mutations disrupt gene regulation and tumor growth.
Researchers successfully replicated Swine Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in various human cell lines, including liver, intestinal, and airway cells. This finding suggests that SADS-CoV has a broad host range and may pose a risk to human health.
Researchers observed cells moving through small channels to understand cell migration in 3D environments. The findings suggest that cancer cells may penetrate tissues and be blocked within small capillaries, potentially allowing them to metastasize.
A new molecular concept dubbed 'range selectivity' allows for targeted drug delivery to diseased cells with high specificity, reducing side effects. By identifying specific receptor densities, researchers can develop nano-sized drug carriers that attach only to diseased cells.
Researchers discovered that cancer mutations follow specific patterns, with internal factors leading to enriched mutations in active domains and external factors resulting in mutations in inactive domains. This understanding may lead to new therapeutic targets and treatment options.
Researchers at KAUST developed a cost-effective, ultrathin SRS lens using laser-based 3D printing, inspired by lighthouse design. The new lens rejects cross-phase modulation background signals, improving imaging efficiency for biological processes like cancer cell growth.
Researchers at Gladstone Institutes have mapped the genetic networks that control regulatory T cells, which act as a brake to suppress immune reactions. The findings could lead to therapies that strengthen or weaken the function of these cells to treat cancer and autoimmune diseases.
Researchers at IRB Barcelona have developed a new method to regulate cell plasticity by inhibiting the protein CDK8, strengthening gene expression for specific cell identities while reducing alternative identities. This approach holds promise for improving chemotherapy reactions and studying embryonic stem cells.
Cells utilize long-distance traveling waves in a self-organized manner to close wounds, guided by intricate interplay of cell movement, sensing, and protein activation. This coupled system enables robust communication of direction over large distances, promoting coordinated behavior for healing and growth.
Researchers from Aarhus University discovered that a circular RNA molecule, ciRS-7, is actually not found in cancer cells but contributes to cancer development through the tumor's microenvironment. This finding challenges previous conclusions and highlights the importance of spatial analyses of patient tumors.
TMDU researchers have engineered a material that can identify and target cancer cells using an antibody-supermolecule conjugate, potentially overcoming drug resistance. The new approach showed enhanced autophagic cell death with lower concentrations of the treatment.
Researchers have created the first atlas of human heart cells, detailing nearly half a million cells and their functions. The database provides a new basis for studying heart disease, which is the leading cause of death worldwide.
Dipanjan Pan and collaborators have developed a novel method to synthesize plasmonic gold nanoparticles within cancer cells, eliminating the need for traditional laboratory methods. The approach has potential applications in x-ray imaging and therapy, with possibilities for targeted drug delivery.
Scientists have developed a new method to combat cancer by using molecular fibers that target the acidic and reactive environment of cancer cells. The approach has shown promising results in laboratory tests, with cancer cells dying within four hours.
Researchers at City of Hope found that Andrographis paniculata, a natural botanical, is effective in killing chemo-resistant colon cancer cells when used in conjunction with chemotherapy. The study's goal was to develop a non-toxic treatment that could succeed in killing cancer cells.
Scientists have identified the SLC25A51 gene as a key player in transporting NAD+ to mitochondria, a critical step in cellular metabolism. This breakthrough could lead to new treatments for diseases such as neurodegenerative disorders and cancer by manipulating NAD+ levels in specific cells.
Researchers discovered that mutations in ARID1A and ARID1B genes lead to the disassembly of cBAF complexes, causing aggressive liver and skin cancer. This finding challenges a proposed strategy to target these proteins for cancer treatment, highlighting the importance of understanding SWI/SNF biology.
Scientists have identified a promising new system to attack tumors directly by combining a small biomolecule with a toxic metal complex. The molecule's luminescent properties allow for detection within cells and demonstrate its toxic effect, paving the way for further research into this innovative theranostic system.
Using tattoo ink and food dyes, researchers have developed new imaging contrast agents that can illuminate cancers, allowing for better differentiation between cancer cells and normal adjacent cells. This breakthrough aims to improve early cancer detection and localization.
Researchers found that UVB exposure expands regulatory T cells expressing proenkephalin and amphiregulin, promoting wound healing and keratinocyte growth. These PENK+UVB-skin Treg cells have a novel therapeutic potential for treating psoriasis and atopic dermatitis.
Researchers at Champalimaud Centre for the Unknown discover that changes in sex cells' nutritional requirements make female flies crave sugar, affecting their food choice and fertility. The study's findings suggest a novel mechanism by which metabolism controls feeding behaviour, potentially relevant to human fertility.
Scientists at Gladstone Institutes have performed a massive cellular energy audit to understand how cells regulate ATP levels. They identified genes and proteins that can be targeted to manipulate cellular energy and treat disease, including neurodegenerative disorders and cancer. The study reveals new pathways for boosting cellular en...
Cells use self-generated chemotaxis to create attractant gradients, allowing them to read local and global information about their surroundings. This process enables cells to navigate vast distances through the human body during embryogenesis and other biological events.
Researchers have used single-cell RNA sequencing to profile transcriptome-level changes in response to DNA damage across individual cancer cells. The study found three distinct groups of genes activated in response to chemotherapy, revealing new insights into why some cancer cells survive while others die.
A new small molecule treatment reduces colon cancer metastasis by locking up cancer cells' ability to change shape and move throughout the body. The treatment cut the rate of cancer metastasis in half, according to a study published in the Proceedings of the National Academy of Sciences.
A team of researchers has identified a novel drug target, 4-hydroxyacetophenone (4-HAP), that activates a protein motor and disrupts biomechanical processes essential to cell motility. In a mouse model, targeting this protein motor reduces the metastasis of colon cancer cells.
A new mechanism for anticancer drug resistance has been discovered in gastric cancer, involving a molecule called Annexin A6. The molecule is secreted by cancer-associated fibroblasts and taken up by gastric cancer cells, leading to increased resistance to treatment.
Scientists have developed a new tool to precisely target cancer cells by distinguishing them from neighboring cells. The Co-LOCKR system uses synthetic proteins to detect specific combinations of cell surface markers, allowing for more precise targeting and improved safety for cancer-killing CAR T cells.
PIM kinases promote metastatic growth by regulating actin fibre formation in the cytoskeleton, supporting PIM-targeted therapies to prevent metastasis. The study provides critical information on factors regulating cancer cell motility, essential for preventing cancer spread.
Researchers developed experimental drugs to lower alpha-ketoglutarate levels, which slowed cancer cell growth and extended mouse lifespans. Higher alpha-ketoglutarate levels were linked to epigenetic changes that kept genes vital for cancer cells active.
Researchers developed a comprehensive study on nanoprodrugs (NPDs) inside cancer cells, revealing their internalization rate, intracellular localization, and degradation. The study shows that NPDs consistently absorbed by cells as intact particles before being transported into lysosomes.
Researchers discovered that simultaneously targeting two energy-production pathways within cancer cells can help overcome the effects of a cancer-causing mutation in DIPG. In mouse models, inhibiting both pathways at once significantly improved survival rates compared to targeting each pathway individually.
Researchers at Weizmann Institute of Science develop new technology to see inside tens of thousands of individual cells at once, identifying a subset of innate immune cells that collaborate with cancer. This breakthrough may lead to immunotherapy treatment for cancer.